Gong LL - Search Results

1

Analysis of the mechanisms underlying the vasorelaxant action of coptisine in rat aortic rings.

Gong LL, Fang LH, Qin HL, Lv Y, Du GH. Gong LL, et al. Am J Chin Med. 2012;40(2):309-20. doi: 10.1142/S0192415X12500243. Am J Chin Med. 2012. PMID: 22419425

2

The vasorelaxant mechanisms of a Rho kinase inhibitor DL0805 in rat thoracic aorta.

Gong L, Peng J, Fang L, Xie P, Si K, Jiao X, Wang L, Du G. Gong L, et al. Molecules. 2012 May 18;17(5):5935-44. doi: 10.3390/molecules17055935. Molecules. 2012. PMID: 22609784 Free PMC article.

3

Coptisine protects rat heart against myocardial ischemia/reperfusion injury by suppressing myocardial apoptosis and inflammation.

Guo J, Wang SB, Yuan TY, Wu YJ, Yan Y, Li L, Xu XN, Gong LL, Qin HL, Fang LH, Du GH. Guo J, et al. Among authors: gong ll. Atherosclerosis. 2013 Dec;231(2):384-91. doi: 10.1016/j.atherosclerosis.2013.10.003. Epub 2013 Oct 16. Atherosclerosis. 2013. PMID: 24267256

4

Coptisine exert cardioprotective effect through anti-oxidative and inhibition of RhoA/Rho kinase pathway on isoproterenol-induced myocardial infarction in rats.

Gong LL, Fang LH, Wang SB, Sun JL, Qin HL, Li XX, Wang SB, Du GH. Gong LL, et al. Atherosclerosis. 2012 May;222(1):50-8. doi: 10.1016/j.atherosclerosis.2012.01.046. Epub 2012 Feb 6. Atherosclerosis. 2012. PMID: 22387061

5

Integration of virtual screening with high-throughput screening for the identification of novel Rho-kinase I inhibitors.

Gong LL, Fang LH, Peng JH, Liu AL, Du GH. Gong LL, et al. J Biotechnol. 2010 Feb 1;145(3):295-303. doi: 10.1016/j.jbiotec.2009.12.003. Epub 2009 Dec 4. J Biotechnol. 2010. PMID: 19963024

6

Effects of salvianolic scid A on plantar microcirculation and peripheral nerve function in diabetic rats.

Yang XY, Sun L, Xu P, Gong LL, Qiang GF, Zhang L, Du GH. Yang XY, et al. Among authors: gong ll. Eur J Pharmacol. 2011 Aug 31;665(1-3):40-6. doi: 10.1016/j.ejphar.2011.03.054. Epub 2011 Apr 15. Eur J Pharmacol. 2011. PMID: 21510928

7

Fluorescence resonance energy transfer assay for high-throughput screening of ADAMTS1 inhibitors.

Peng J, Gong L, Si K, Bai X, Du G. Peng J, et al. Molecules. 2011 Dec 20;16(12):10709-21. doi: 10.3390/molecules161210709. Molecules. 2011. PMID: 22186957 Free PMC article.

8

Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis.

Gong LL, Peng JH, Han FF, Zhu J, Fang LH, Wang YH, Du GH, Wang HY, Liu LH. Gong LL, et al. Thromb Res. 2012 Sep;130(3):e43-51. doi: 10.1016/j.thromres.2012.06.015. Epub 2012 Jul 6. Thromb Res. 2012. PMID: 22771216

9

Genetic risk factors for glucocorticoid-induced osteonecrosis: a meta-analysis.

Gong LL, Fang LH, Wang HY, Peng JH, Si K, Zhu J, Han FF, Wang YH, Du GH, Pei LX, Liu LH. Gong LL, et al. Steroids. 2013 Apr;78(4):401-8. doi: 10.1016/j.steroids.2013.01.004. Epub 2013 Jan 25. Steroids. 2013. PMID: 23357434

10

Pharmacokinetics of enteric-coated mycophenolate sodium in Chinese renal transplantation recipients.

Qiu K, Tian H, Wang W, Hu XP, Li XB, Gong LL, Luo W, Liu LH, Zhang XD, Yin H. Qiu K, et al. Among authors: gong ll. Chin Med J (Engl). 2012 Dec;125(23):4226-32. Chin Med J (Engl). 2012. PMID: 23217391 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters